Polar Capital Biotech R Inc

Performance History31/01/2019
Growth of 1,000 (EUR)
Polar Capital Biotech R Inc
Fund25.2-5.114.30.613.7
+/-Cat5.812.08.39.61.1
+/-Idx5.34.410.50.18.0
 
Key Stats
NAV
15/02/2019
 USD 24.38
Day Change 1.60%
Morningstar Category™ Sector Equity Biotechnology
ISIN IE00B3XLHR60
Fund Size (Mil)
15/02/2019
 USD 495.63
Share Class Size (Mil)
15/02/2019
 USD 176.71
Max Initial Charge 5.00%
Ongoing Charge
15/02/2018
  1.73%
Investment Objective: Polar Capital Biotech R Inc
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation.
Returns
Trailing Returns (GBP)15/02/2019
YTD19.42
3 Years Annualised19.88
5 Years Annualised17.25
10 Years Annualised-
12 Month Yield 0.00
Dividend Paying Frequency Annually
Management
Manager Name
Start Date
David Pinniger
31/10/2013
Inception Date
31/10/2013
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMSCI World/Biotechnology NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingNo
OtherNot Specific
Portfolio Profile for  Polar Capital Biotech R Inc31/12/2018
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks91.510.0091.51
Bonds0.000.000.00
Cash8.490.008.49
Other0.000.000.00
Top 5 Regions%
United States70.81
Eurozone17.32
Europe - ex Euro5.42
United Kingdom3.22
Japan2.12
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Regeneron Pharmaceuticals IncHealthcareHealthcare6.89
Alexion Pharmaceuticals IncHealthcareHealthcare6.85
Incyte CorpHealthcareHealthcare6.24
argenx SEHealthcareHealthcare5.62
BeiGene Ltd ADRHealthcareHealthcare5.18
Polar Capital Biotech R Inc